118 related articles for article (PubMed ID: 15234636)
1. Quality specifications and the assessment of the biochemical risk of atherosclerosis.
Rifai N; Warnick GR
Clin Chim Acta; 2004 Aug; 346(1):55-64. PubMed ID: 15234636
[TBL] [Abstract][Full Text] [Related]
2. Mixed dyslipidemia among patients using lipid-lowering therapy in French general practice: an observational study.
Van Ganse E; Laforest L; Burke T; Phatak H; Souchet T
Clin Ther; 2007 Aug; 29(8):1671-81. PubMed ID: 17919548
[TBL] [Abstract][Full Text] [Related]
3. Relationship of subclinical coronary atherosclerosis and National Cholesterol Education Panel guidelines in asymptomatic Brazilian men.
Nasir K; Santos RD; Roguin A; Carvalho JA; Meneghello R; Blumenthal RS
Int J Cardiol; 2006 Mar; 108(1):68-75. PubMed ID: 16516700
[TBL] [Abstract][Full Text] [Related]
4. Analytical performance of a direct assay for LDL-cholesterol: a comparative assessment versus Friedewald's formula.
Türkalp I; Cil Z; Ozkazanç D
Anadolu Kardiyol Derg; 2005 Mar; 5(1):13-7. PubMed ID: 15755695
[TBL] [Abstract][Full Text] [Related]
5. The independent correlation between high-density lipoprotein cholesterol and subsequent major adverse coronary events.
Koro CE; Bowlin SJ; Stump TE; Sprecher DL; Tierney WM
Am Heart J; 2006 Mar; 151(3):755.e1-755.e6. PubMed ID: 16504648
[TBL] [Abstract][Full Text] [Related]
6. Multivariate assessment of lipid parameters as predictors of coronary heart disease among postmenopausal women: potential implications for clinical guidelines.
Shai I; Rimm EB; Hankinson SE; Curhan G; Manson JE; Rifai N; Stampfer MJ; Ma J
Circulation; 2004 Nov; 110(18):2824-30. PubMed ID: 15492318
[TBL] [Abstract][Full Text] [Related]
7. Extent to which accepted serum lipid goals are achieved in a contemporary general medical population with coronary heart disease risk equivalents.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2006 Nov; 98(9):1231-3. PubMed ID: 17056335
[TBL] [Abstract][Full Text] [Related]
8. Rationale for targeted rather than population based screening with C-reactive protein using the National Health and Nutrition Examination Survey (1999 to 2002).
Guttormsen BN; Stein JH; McBride PE; Cullen MW; Gangnon R; Keevil JG
Am J Cardiol; 2007 Oct; 100(7):1130-3. PubMed ID: 17884376
[TBL] [Abstract][Full Text] [Related]
9. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
[TBL] [Abstract][Full Text] [Related]
10. High attributable risk of elevated C-reactive protein level to conventional coronary heart disease risk factors: the Third National Health and Nutrition Examination Survey.
Miller M; Zhan M; Havas S
Arch Intern Med; 2005 Oct; 165(18):2063-8. PubMed ID: 16216995
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk factors in middle-aged women with subclinical hypothyroidism.
Luboshitzky R; Herer P
Neuro Endocrinol Lett; 2004 Aug; 25(4):262-6. PubMed ID: 15361814
[TBL] [Abstract][Full Text] [Related]
12. A new method of measuring C-reactive protein, with a low limit of detection, suitable for risk assessment of coronary heart disease.
Eda S; Kaufmann J; Molwitz M; Vorberg E
Scand J Clin Lab Invest Suppl; 1999; 230():32-5. PubMed ID: 10389199
[TBL] [Abstract][Full Text] [Related]
13. Relation of clinical benefit of raising high-density lipoprotein cholesterol to serum levels of low-density lipoprotein cholesterol in patients with coronary heart disease (from the Bezafibrate Infarction Prevention Trial).
Goldenberg I; Benderly M; Sidi R; Boyko V; Tenenbaum A; Tanne D; Behar S
Am J Cardiol; 2009 Jan; 103(1):41-5. PubMed ID: 19101227
[TBL] [Abstract][Full Text] [Related]
14. Brief review and critical examination of the use of hs-CRP for cardiac risk assessment with the conclusion that it is premature to use this test.
Levinson SS
Clin Chim Acta; 2005 Jun; 356(1-2):1-8. PubMed ID: 15936299
[TBL] [Abstract][Full Text] [Related]
15. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22.
Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E
Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of low high-density lipoprotein cholesterol in patients with documented coronary heart disease or risk equivalent and controlled low-density lipoprotein cholesterol.
Alsheikh-Ali AA; Lin JL; Abourjaily P; Ahearn D; Kuvin JT; Karas RH
Am J Cardiol; 2007 Nov; 100(10):1499-501. PubMed ID: 17996508
[TBL] [Abstract][Full Text] [Related]
17. Laboratory measurement of lipid and lipoprotein risk factors.
Warnick GR
Scand J Clin Lab Invest Suppl; 1990; 198():9-19. PubMed ID: 2189213
[TBL] [Abstract][Full Text] [Related]
18. Carbohydrate intake is correlated with biomarkers for coronary heart disease in a population of overweight premenopausal women.
Lofgren IE; Herron KL; West KL; Zern TL; Patalay M; Koo SI; Fernandez ML
J Nutr Biochem; 2005 Apr; 16(4):245-50. PubMed ID: 15808329
[TBL] [Abstract][Full Text] [Related]
19. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
20. Achievement of optimal combined lipid values in a managed care setting: is a new treatment paradigm needed?
Sarawate CA; Cziraky MJ; Stanek EJ; Willey VJ; Corbelli JC; Charland SL
Clin Ther; 2007 Jan; 29(1):196-209. PubMed ID: 17379061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
